Centre defends pharma marketing practice code in SC, claims adequacy
Responding to a sales rep body’s demand for statutory backing to the Pharmaceutical Marketing Practices code UCMCP, the Centre said it was taking progressive steps to evaluate the necessity of making the code statutory, adding that it was a ‘time-consuming process, which cannot be completed in haste’.
Govt advises manufacturing companies on prices of phosphoric acid
The International prices of phosphoric acid are decided on quarterly basis. The official said that the suppliers are to fix the price for next quarter staring from October.
Heart disease no more an old-age problem, common in the younger population, say cardiologists
Poor lifestyle choices like smoking, a sedentary lifestyle, and over-strenuous exercise without a doctor’s advice lead people to develop risk factors like high blood pressure, cholesterol, a dilated heart, and more.
Early intervention in rare disease can save lives, Centre’s policy an encouraging step: Bruno Jolain, Roche India
The pharma company says the funding aspect of drug for spinal muscular atrophy remains a challenge adding that they are working hard to find a solution.
Mental healthcare start-up Lissun raises $1 million in pre-seed round from IvyCap ventures
The start-up says the funds raised will be used to develop technology and foster healthcare partnerships in 25 cities across India.
Private hospitals concerned over removal of payment clause in revised CGHS empanelment pact
According to private hospital associations, the government has added detailed clauses on terms of operation, termination, penalty and performance, but there are no payment terms in the agreement.
Cadila in talks with Centre, states for supply of three-dose rabies vaccine
The new vaccine cuts short the duration of treatment and saves lives by making compliance easier.
Dementia, as a fallout of COVID-19, emerges as a threat to India’s elderly
According to estimates, 5 out of every 100 elderly people in India have dementia and many more are at high risk of developing the condition.
J&J to challenge Maharashtra FDA's order cancelling license of its baby powder
"We strongly disagree with this order and will appeal to the authorities within the 90 days’ time given to us," a spokesperson of the company told Moneycontrol.
‘Not able to sell, what next’: Chemist body asks Johnson and Johnson as FDA orders withdrawal of baby powder from market
Industry experts want the Drug Controller of India to intervene in the matter of J&J baby powder failing the quality test in the country.
'Withdraw baby powder from the market': Maharashtra FDA tells J&J
The order was issued as the product failed the pH test. It does not say anything about the use of asbestos, a carcinogen, in the product, over which Johnson & Johnson faces many lawsuits.
Bengaluru's traffic concern for patients, need to make infrastructure sustainable: Doctor who ran to perform surgery
The gastroenterology surgeon says he recorded a small video while running towards the hospital to show close family and friends, the traffic situation in Sarjapur, adding that it was never meant to be shared with the public at large.
Injecting local anaesthesia agent around tumour in breast cancer patients can increase cure rates: Study
Conducted by investigators at 11 cancer centres in India including Tata Memorial Centre in Mumbai over an 11-year period, it has shown that injecting 0.5 percent lidocaine, a common local anaesthesia agent, around the tumour increases cure rates.
Biological-E developing Omicron specific vaccine, contemplating it to be used as bivalent jab: Mahima Datla, CEO
The managing director of vaccine manufacturing company says regulatory framework along with financing and market predictability are important bottlenecks in developing variant specific vaccines against evolving coronavirus
Micro Labs gets clean chit from pharma body on allegations of spending Rs 1,000 crore on Dolo 650
The company hasn't distributed freebies as claimed by tax authorities, Jayaraj Govindaraju, Executive Vice President Marketing and Communication, told Moneycontrol
Zenara pharma launches COVID-19 antiviral pills
Paxzen, a two-drug combination, is the generic version of Pfizer's anti-covid pill Paxlovid. A box of Paxzen will cost Rs 5,200
MC Explains | Amid rising cases of cervical cancer, an affordable vaccine that can be a game changer
More than a lakh women get cervical cancer in the country every year, making it the second most common cancer among Indian women after breast cancer
Delhi HC grants bail to Eswara Reddy, Pravin Kumar in CDSCO bribery case, says no flight risk
The judge said the trial in the matter would take ample time and noted that the credibility of circumstantial evidence in the case would have to be assessed.
Bharat Biotech's nasal COVID vaccine gets DCGI nod
According to the company, nasal vaccine iNCOVACC has double benefit of enabling faster development of variant specific vaccines and easy nasal delivery that enables mass immunization to protect from emerging variants of concern.
As Centre readies ‘Heal in India’ portal, hospital chains suggest a slew of measures on medical tourism
Large private hospital chains have sought ease in securing visas and suggested that a welcome desk be set up at international airports in a separate lounge where arriving patients can rest
Serum Institute to roll out home-grown cervical cancer vaccine at one-tenth cost
Cervavac to be approximately priced at Rs 200-400. “It will be available at a far cheaper and more affordable price than the jabs being imported into the country,” says CEO Adar Poonawalla. At present, two doses of the vaccine can cost Rs 8,000
Mansukh Mandaviya asks pharma industry to tackle spurious drug menace
Out of 84,874 samples tested by various drug controllers, up to 2,652 samples were not of standard quality last year, the Centre informed Parliament in July.
AI, ML and robotics to drive India’s healthcare: Prathap Reddy, Apollo Chairman
Over the next few years, the Apollo Group will invest in spreading footprint in key regions, and expand specialty centres to more locations
To help medical supplies, test samples reach difficult terrain, ICMR initiates four drone studies
The top medical research body is trying to find out whether drones can be used to transport medical supplies to far-flung areas.
- JSW Energy, Atul Auto, Sterlite Technologies & Tata Steel: Top Stocks To Watch On Oct 06, 2022 Watch more
- How To Buy Gold This Festive Season Watch more
- Watch: Five Unique Dussehra Celebrations Across India Watch more
- What are corporate bonds and how to invest in them | Personal Finance Watch more
- Best Credit Cards For Shopping This Festive Season | Credit Cards For Online Shopping | Festive Sales 2022 Watch more